Dov Hershkovitz
Overview
Explore the profile of Dov Hershkovitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
1244
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kampel L, Feldstein S, Tsuriel S, Trejo L, Horowitz G, Warshavsky A, et al.
Radiother Oncol
. 2025 Jan;
204:110714.
PMID: 39800270
Head and neck squamous cell carcinomas (HNSCC) frequently recur, and patients often develop second primary tumors. Their distinction is clinically challenging. TP53 mutational heterogeneity may indicate novel molecular events rather...
2.
Kurolap A, Chai Gadot C, Adiv O, Hershkovitz T, Avitan-Hersh E, Martin L, et al.
Ann Intern Med
. 2024 Dec;
178(1):39-49.
PMID: 39715557
Background: Yellow nail syndrome (YNS) is a rare disorder characterized by a triad of yellow dystrophic nails, lymphedema, and chronic lung disease. Most patients present in adulthood, with only a...
3.
Pellegrino B, David K, Rabani S, Lampert B, Tran T, Doherty E, et al.
PLoS Biol
. 2024 Nov;
22(11):e3002905.
PMID: 39576827
CD74 is a cell-surface receptor for the cytokine macrophage migration inhibitory factor (MIF). MIF binding to CD74 induces a signaling cascade resulting in the release of its cytosolic intracellular domain...
4.
Fahoum I, Tsuriel S, Rattner D, Greenberg A, Zubkov A, Naamneh R, et al.
Diagn Pathol
. 2024 Jun;
19(1):75.
PMID: 38851736
Background & Objectives: Tumor grade determines prognosis in urothelial carcinoma. The classification of low and high grade is based on nuclear morphological features that include nuclear size, hyperchromasia and pleomorphism....
5.
Fahoum I, Naamneh R, Silberberg K, Hagege R, Hershkovitz D
Technol Cancer Res Treat
. 2024 May;
23:15330338241257479.
PMID: 38803309
Assessment of muscularis propria invasion is a crucial step in the management of urothelial carcinoma since it necessitates aggressive treatment. The diagnosis of muscle invasion is a challenging process for...
6.
Malapelle U, Leighl N, Addeo A, Hershkovitz D, Hochmair M, Khorshid O, et al.
Br J Cancer
. 2024 May;
131(2):212-219.
PMID: 38750115
Non-small cell lung cancer is a heterogeneous disease and molecular characterisation plays an important role in its clinical management. Next-generation sequencing-based panel testing enables many molecular alterations to be interrogated...
7.
Greenberg A, Samueli B, Farkash S, Zohar Y, Ish-Shalom S, Hagege R, et al.
Diagn Pathol
. 2024 Feb;
19(1):26.
PMID: 38321431
Background: Differences in the preparation, staining and scanning of digital pathology slides create significant pre-analytic variability. Algorithm-assisted tools must be able to contend with this variability in order to be...
8.
Perry C, Greenberg O, Haberman S, Herskovitz N, Gazy I, Avinoam A, et al.
Cancers (Basel)
. 2023 Nov;
15(21).
PMID: 37958379
Deep learning applications are emerging as promising new tools that can support the diagnosis and classification of different cancer types. While such solutions hold great potential for hematological malignancies, there...
9.
Fahoum I, Hershkovitz D, Erental A, Argani P
Int J Surg Pathol
. 2023 Oct;
32(4):821-824.
PMID: 37844624
The classic morphology of clear cell renal cell carcinoma consists of nests of cells with clear cytoplasm. Nevertheless, other histologic patterns may be seen including cells with eosinophilic cytoplasm, bizarre...
10.
Kampel L, Feldstein S, Tsuriel S, Hannes V, Carmel Neiderman N, Horowitz G, et al.
Biomolecules
. 2023 Sep;
13(9).
PMID: 37759818
Circulating tumor DNA (ctDNA) has been suggested as a surrogate biomarker for early detection of cancer recurrence. We aimed to explore the utility of ctDNA as a noninvasive prognostic biomarker...